✦ LIBER ✦

Emerging therapies in the long-term management of hyperuricaemia and gout

✍ Scribed by L. K. Stamp; J. L. O’Donnell; P. T Chapman

Book ID: 109001970
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 113 KB
Volume: 37
Category: Article
ISSN: 1444-0903
DOI: 10.1111/j.1445-5994.2007.01315.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Advances in the management of gout and h

Advances in the management of gout and hyperuricaemia

✍ Hoskison, T. K.; Wortmann, R. L. 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 244 KB

Systematic review of the prevalence of g

Systematic review of the prevalence of gout and hyperuricaemia in Australia

✍ P. C. Robinson; W. J. Taylor; T. R. Merriman 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 639 KB

Emergent and Long-term Management of Lar

Emergent and Long-term Management of Laryngotracheal Relapsing Polychondritis

✍ Nici Eddy Bothwell; Thomas Peyton Nowlin IV; Benjamin B. Cable 📂 Article 📅 2005 🏛 SAGE Publications 🌐 English ⚖ 52 KB

Anti-Interleukin-1 Therapy in the Manage

Anti-Interleukin-1 Therapy in the Management of Gout

✍ Schlesinger, Naomi 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 228 KB

Febuxostat: a non-purine, selective inhi

Febuxostat: a non-purine, selective inhibitor of xanthine oxidase for the management of hyperuricaemia in patients with gout

✍ Schumacher Jr, H Ralph 📂 Article 📅 2005 🏛 Informa plc 🌐 English ⚖ 275 KB

Adjuvant therapy and long-term managemen

Adjuvant therapy and long-term management of differentiated thyroid carcinoma

✍ Steven I. Sherman 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 28 KB 👁 1 views

As with most therapies for differentiated thyroid carcinoma, there is little consensus about optimal use of postoperative adjuvant therapies or long-term follow-up strategies. However, an increasing body of data indicates that most patients can benefit from postoperative radioiodine ablation followe